Find Academic Supervisors

Christian EulerView profile

Assistant Professor

• Metabolic Engineering
• Synthetic Biology
• Biomanufacturing
• +3 more

Christian Euler is an Assistant Professor at the University of Waterloo, specializing in metabolic engineering, synthetic biology, and biomanufacturing. His research focuses on integrating systems biology approaches with biochemical engineering to address challenges in sustainable bioprocesses, microbial physiology, and protein design. Key emphases include metabolic network modeling, photobioreactor optimization, and cross-feeding bacterial consortia for plastic degradation. Dr. Euler’s work bridges theoretical systems analysis with practical biotechnological applications, emphasizing thermodynamic constraints, flux sensing mechanisms, and machine learning-driven process optimization. His contributions span from foundational studies on proteome dynamics and metabolic flux regulation to applied innovations in bio-based manufacturing and immunomodulatory polymer design. His research portfolio demonstrates interdisciplinary collaboration, combining principles from biochemistry, chemical engineering, and computer science. Notable areas of exploration include leveraging Cupriavidus necator for bio-based production, developing context-dependent metabolic sensors, and designing synthetic biology tools for industrial biotechnology. No scientific awards are listed in the current profile. His advising and grant activities remain unspecified in the provided data. Active research themes include scale-up strategies for biomass production, sustainable plastic upcycling systems, and systems-level understanding of microbial adaptation processes.

Jaleh BararView profile

Professor

• Cancer Drug Development
• Gene and Protein Therapeutics
• Cellular Drug Delivery
• +3 more

Dr. Jaleh Barar is a Professor at Nova Southeastern University's Barry and Judy Silverman College of Pharmacy, specializing in multifunctional drug delivery systems and nanomedicine. She holds a Pharm.D. from Tabriz University of Medical Sciences (1994) and a Ph.D. from Cardiff University (2004). As Editor-in-Chief of Bioimpacts , she contributes to advancing biomedical research. Her teaching spans courses like Pharmacy Skill Development II and Advanced Topics in Pharmaceutical Sciences . Her research focuses on cancer drug development, gene/protein therapeutics, and targeted nanomedicines. Key achievements include over 230 peer-reviewed articles (H-index 49), 17 book chapters, and recognition as a top 1% global scientist by WoS-ESI since 2020. She has supervised 40+ PharmD and 20+ Ph.D. students, emphasizing translational research in drug delivery and regenerative medicine. Dr. Barar’s work bridges nanotechnology and medicine, with innovations in hydrogels, aptamer-functionalized nanoparticles, and mRNA vaccine carriers. Her studies explore applications in osteogenesis, ocular delivery, and photothermal cancer therapy. Her awards reflect her global impact in biomedical innovation. Her lab focuses on scaffold-free tissue engineering, smart biomaterials, and nanoscale theranostics. She collaborates internationally to address challenges in drug delivery, with a focus on overcoming biological barriers and enhancing therapeutic efficacy through nanomedicine platforms.

• Nanomedicine
• Nanosafety
• Drug Delivery Systems
• +5 more

Professor Wojciech Chrzanowski is a Professor of Nanomedicine at the University of Sydney, leading the Pharmaceutical Sciences unit within the Sydney Pharmacy School (Faculty of Medicine and Health). He also holds a Visiting Professorship at Uppsala University and serves as President of the Asian Federation for Pharmaceutical Sciences. His research focuses on nanomedicine, nanosafety, and drug delivery systems, with significant contributions to lung tissue repair and nano-bio-characterisation. He established the Nano-Medical Innovations Labs and heads the Nano-Bio-Characterisation facility housing advanced microscopy systems. Chrzanowski earned his PhD from Silesian University of Technology and a DSc from the Polish Academy of Sciences. Notable accolades include the SOAR Fellowship (2016), Endeavour Executive Award (2012), and the ProIMAGE Contest 2012. His work spans over 200 peer-reviewed papers and 50 conference proceedings, with patents in drug delivery and biomaterials. Research interests include developing stimuli-responsive drug carriers, nanosafety assessment using 3D bioprinted tissue models, and extracellular vesicle-based therapies. He is a member of the Sydney Southeast Asia Centre, Centre for Drug Discovery Innovation, and University of Sydney Nano Institute. Key projects involve lung repair via stem cells/exosomes and antimicrobial gallium surface coatings for medical implants. His lab’s advanced facilities enable multifaceted nanoscale analysis of materials and biological interactions.

• Medicinal Chemistry
• Bioinorganic Chemistry
• Imaging Agents and Theranostics
• +4 more

Professor Rachel Codd is a leading academic in Bioinorganic and Medicinal Chemistry at the University of Sydney's School of Medical Sciences. She holds roles including membership in the Centre for Drug Discovery Innovation and has held positions from Lecturer (2001) to Professor (2017). Her research focuses on bacterial siderophores, metal chelators, and their applications in imaging/therapy, metal dyshomeostasis, and environmental remediation. Her interdisciplinary work spans chemistry, molecular biology, and biotechnology, with innovations in chelator design for PET imaging and therapeutics. Education: BSc (Hons) and PhD in Chemistry from the University of Sydney (1992, 1998). Postdoctoral roles included the University of New South Wales (1997-1999) and University of Arizona (1999-2000). Research interests include: metal-binding compounds for imaging/therapy, siderophore discovery, and iron chelators for transfusion-dependent iron overload. Collaborations span institutions like QIMR Berghofer, ANSTO, and Telix Pharmaceuticals. Awards include the Biota Medal for Medicinal Chemistry (2010), Vice Chancellor's Award for Excellence (2016), and election as a Fellow of the Royal Australian Chemical Institute (FRACI). She leads the Medicinal Chemistry major in the Bachelor of Science and Advanced Studies. Current projects include metal-templated synthesis of hydroxamic acids, biosynthetic siderophore discovery, and chelator development for PET radiometals. Her lab explores chemo-enzymatic approaches for Ga(III) and Zr(IV) coordination chemistry.

Matthew D. MooreView profile

Associate Professor

• Food Microbiology
• Foodborne Viruses
• Human Norovirus
• +5 more

Matthew D. Moore is an Associate Professor in the Department of Food Science at the University of Massachusetts Amherst. His research focuses on foodborne virology , particularly human noroviruses , and their interactions with bacterial microbiomes. He develops Portable detection platforms Viral inactivation strategies Sample concentration methods for food and environmental virology. His recent publications emphasize virus-bacteria interactions , aptamer-based biosensors , and nanopore detection technologies . Collaborations span virology, microbiology, and engineering disciplines. Scientific Awards include the Eric A. Decker Scholar (2024-2030) and IFT Outstanding Young Scientist Award (2024). Key students include Aref Soorneedi Cassandra Stoufer Minjoo Kim in virology and food safety projects.

Peiyi ShenView profile

Lecturer

• Food Science
• Nutritional Biology
• Gut Microbiota
• +7 more

Peiyi Shen is a Lecturer and Chief Undergraduate Advisor in the Department of Food Science at the University of Massachusetts Amherst. Their research focuses on food bioactives, gut microbiota modulation, and functional food development. Shen's work integrates food chemistry, nutritional biology, and biotechnology to explore novel approaches in obesity research, aging mechanisms, and probiotic delivery systems. They utilize C. elegans as a primary model organism for studying food bioactive impacts on healthspan and disease processes. Key research areas include dietary interventions using marine algae, plant polyphenols, and fermented products to modulate gut health and inflammatory responses. Shen has pioneered studies on nanoemulsion-based delivery systems for enhancing bioavailability of nutraceuticals, as well as thermal processing effects on food matrix structures. Their work also addresses challenges in protein functionality through enzymatic and physical modification techniques. Recent studies highlight the anti-inflammatory effects of Laminaria japonica in colitis models, the role of tea polysaccharides in probiotic encapsulation, and the obesity-mitigating potential of cranberry and berry phenolics in C. elegans. This multidisciplinary approach bridges fundamental food science with translational health applications.

Seyed Hosseini GhazviniView profile

Researcher

• Organic Chemistry
• Biochemistry
• Quantum Chemistry
• +3 more

Seyed Hosseini Ghazvini holds a Doctor of Philosophy and is affiliated with the School of Molecular Sciences. His research focuses on interdisciplinary areas spanning organic chemistry, quantum chemistry, biochemistry, and materials science. Key interests include alkyne isomerization, flavonoid pharmacology, mixed-valence complexes, and electrochemical processes. Recent work emphasizes computational studies on metal complexes and the development of bio-based materials for sustainable applications. His research contributions include studies on molecular mechanisms of organic reactions, drug design targeting neurological disorders, and catalytic systems for green chemistry. Articles highlight advancements in understanding reaction dynamics, enzyme inhibition, and interfacial electron transfer phenomena. No awards or grants are explicitly mentioned in the provided data. Collaborations span multiple institutions, with a focus on international partnerships in chemical and biochemical research.

• Pharmaceutical Technology
• Dermatological Applications
• Nanodispersions
• +6 more

Prof. Rolf Daniels is a Professor in the Department of Pharmaceutical Technology at the University of Tübingen’s Faculty of Science, located at Auf der Morgenstelle 8, Tübingen. His research focuses on innovative drug delivery systems, including nanodispersions, electrospun fibers, and formulations derived from natural extracts. He specializes in dermatological applications, wound healing, and phytochemical characterization of medicinal plants like Matricaria recutita (chamomile) and Hypericum perforatum (St. John’s wort). His work spans supercritical fluid extraction, emulsion science, and the development of biomaterials for controlled drug release. Key contributions include studies on betulin-containing foams, probiotic orodispersible tablets, and the use of alkyl polyglucosides in topical formulations. He has also explored the impact of fermentation on plant extracts and the optimization of oral drug delivery systems for pediatric use. Prof. Daniels’ publications emphasize interdisciplinary approaches, combining analytical chemistry, material science, and pharmacology. His recent work (2023–2025) highlights advancements in phase-reversal foams, electrospun wound dressings, and co-amorphous drug formulations. While no specific awards are listed, his extensive publication record reflects sustained contributions to pharmaceutical technology. His research also includes collaborations on formulation stability, skin permeation studies using confocal Raman microscopy, and the development of thixotropic silicone oils for medical applications. Ongoing projects involve supercritical fluid technology for 3D-printed drug delivery systems and the evaluation of natural preservatives in semisolid dosage forms.

• Organometallic Chemistry
• Antimicrobials
• Medicinal Chemistry
• +3 more

Professor Philip Andrews is a distinguished academic at Monash University's School of Chemistry, serving as Professor and Interim Head. His research focuses on discovering bioactive metal compounds, antimicrobial agents, and medical imaging technologies. He holds affiliations with the Monash Centre to Impact AMR and the Victorian Heart Institute. Andrews completed his PhD at the University of Strathclyde (1992) and has held prestigious fellowships, including Alexander von Humboldt and Royal Society awards. His work spans organometallic chemistry, medicinal chemistry, and sustainable chemistry, contributing to UN SDGs in health and sustainability. Education PhD in Chemistry, University of Strathclyde (1992), Thesis: 'Synthesis and Characterisation of Novel Alkali Metal Amides.' Research Interests Andrews’ research integrates chemistry with medicine and sustainability, emphasizing: Development of metal-based antimicrobial agents targeting drug-resistant pathogens like Klebsiella and Leishmania. Design of bismuth and gallium complexes for medical imaging and therapeutics. Green synthesis methods, including microwave-assisted and solvent-free approaches. Grants & Projects He leads major projects like the ARC Training Centre for Advanced Radiochemical Technologies (2024–2029) and Combating Antimicrobial Resistance with Bismuth, Gallium, and Indium (2022–2026). His collaborations span global institutions, addressing AMR and sustainable materials. Awards Recipient of the 2022 prize 'From grave to cradle: Hunting new antimicrobials through sustainable drug discovery.' Fellow of the Royal Society of Chemistry and Royal Australian Chemical Institute. Labs & Teams Andrews directs interdisciplinary teams advancing antimicrobial materials and medical imaging agents, with active partnerships in industry and academia.

• Nanomedicine
• Drug Delivery Systems
• Marine-Derived Biomaterials
• +3 more

Ana Grenha is a Professor at the University of Algarve (UALG) and a Senior Researcher at the Centre of Marine Sciences (CCMAR). She holds a PhD in Pharmaceutical Technology from the University of Santiago de Compostela (2007) and obtained her Habilitation in Pharmaceutical Technology from the University of Lisbon in 2022. Her research focuses on marine-derived biomaterials for drug delivery systems, with particular emphasis on polysaccharide nanoparticles, inhalation therapies, and antibacterial treatments. She leads the Marine Molecular Bioengineering group and has contributed to projects like GERMROS , exploring antioxidant capacities in spermatogonia. Awards include the inaugural UAlg Researcher Award 2022 and the Robalo Cordeiro Award for innovative vaccination research. Prof. Grenha has supervised PhD students such as Susana Rodrigues and Ludmylla Cunha, and her work spans nanomedicine, respiratory drug delivery, and sustainable biomaterials from marine organisms. She actively participates in academic events, including thesis defenses and scientific conferences, and has published extensively on topics like fucoidan-based nanoparticles, chitosan microencapsulation, and tuberculosis therapy innovations. Education: PhD in Pharmacy-Pharmaceutical Technology, University of Santiago de Compostela, 2007 Habilitation in Pharmaceutical Technology, University of Lisbon, 2022 Awards: Prémio Investigador UAlg 2022 Best Oral Communication Award (36th Pulmonology Congress, 2023) Robalo Cordeiro SPP/AstraZeneca/Novartis Award (2020) Labs/Teams: Marine Molecular Bioengineering Group at CCMAR

Mustafa O. GulerView profile

Teaching Professor

• Peptide Nanomaterials
• Biomedical Engineering
• Drug Delivery Systems
• +2 more

Dr. Mustafa O. Guler is Senior Instructional Professor and Director of Experiential Learning at the University of Chicago's Pritzker School of Molecular Engineering. A Fellow of the Royal Society of Chemistry, his research develops peptide-based biomaterials for therapeutic applications. His laboratory focuses on molecular engineering of self-assembling peptide systems for regenerative medicine, drug delivery, and immunoengineering. Key innovations include: glycosaminoglycan-mimetic nanofibers for cartilage regeneration; neuroactive scaffolds for spinal cord repair; and antigen-presenting nanomaterials for cancer immunotherapy. Materials are designed through computational modeling and validated in disease models. Publications demonstrate cross-disciplinary integration of peptide chemistry, nanomaterial science, and biomedical engineering. Recent work emphasizes translational applications in ocular drug delivery, neural regeneration, and immunomodulation. He maintains editorial roles for Scientific Reports, RSC Advances, and Molecules.

Benjamin RossView profile

Senior Lecturer

• Medicinal Chemistry
• Drug Discovery
• Alzheimer's Disease
• +2 more

Dr. Benjamin Ross is a Senior Lecturer in the School of Pharmacy and Pharmaceutical Sciences at the University of Queensland. His research applies computer-aided drug design and synthetic chemistry to develop novel therapeutics for cancer, viral infections, and neurodegenerative disorders like Alzheimer's disease. Education includes: Bachelor of Science (Honours) from University of Queensland PhD in Medicinal Chemistry from University of Queensland Research integrates computational approaches with experimental validation using biochemical assays and disease models. Key areas include acetylcholinesterase inhibitors for Alzheimer's, antiviral nanoparticles, amyloid inhibition strategies, and advanced drug delivery systems using functionalized nanomaterials. Recent publications demonstrate strong trends in nanomedicine (particularly silica-based delivery systems) and computational drug discovery. Later works increasingly focus on translational applications like 3D-printed personalized medicines and plant-derived bioactive compounds. Dr. Ross teaches undergraduate pharmacy courses including Drug Discovery, Dosage Form Design, and coordinates the research higher degrees program. He currently supervises multiple PhD students working on Alzheimer's therapeutics, antiviral nanoparticles, and computer-aided drug design. His research group collaborates internationally on projects involving enzyme-responsive drug delivery and biomimetic hydrogels.

Craig WilliamsView profile

Professor

• Organic Synthesis
• Natural Products
• Medicinal Chemistry
• +3 more

Professor Craig Williams holds a position at the University of Queensland's School of Chemistry and Molecular Biosciences. His research integrates organic synthesis, medicinal chemistry, and natural products discovery with applications in drug development and materials science. His expertise spans total synthesis of complex natural products, development of novel synthetic methodologies, and design of bioactive compounds including pharmaceutical agents and agrochemicals. Current investigations explore cage compounds, organometallic catalysis, and sustainable materials derived from natural precursors. Professor Williams' publications demonstrate consistent innovation across multiple domains: natural product structural elucidation, development of electrochemically-driven synthetic methods, therapeutic agent discovery, and agricultural chemistry. His work frequently bridges fundamental organic chemistry with practical applications in medicine and agriculture. Recognition includes the Thieme Chemistry Journals Award (2007), Australian Research Council Future Fellowship (2011), and SCMB Award for Outstanding Contribution to Research (2019). He has supervised over 120 researchers and maintains international collaborations.

• Nanobioengineering
• Biomaterials
• Biophysics
• +3 more

Marina Inés Giannotti is a prominent researcher at the Institute for Bioengineering of Catalonia (IBEC) , specializing in Nanobioengineering , Biomaterials , and Biophysics . Her work focuses on understanding the nanomechanics of lipid membranes , protein-lipid interactions , and electroactive materials for biomedical applications. She has been involved in groundbreaking studies using atomic force microscopy (AFM) and force spectroscopy to investigate membrane dynamics, protein stability, and material-cell interactions. Her research spans multiple disciplines, including cell membrane biomechanics , photosynthetic charge transport , and polymer-based drug delivery systems . Recent publications highlight her contributions to collagen VI-related muscular dystrophies , omega-3 fatty acid effects on brain membranes , and electroactive material optimization for cell therapies . While no awards or students are explicitly listed, her collaborative projects with institutions like the University of Barcelona and UPC demonstrate her integration into interdisciplinary research networks. Notable collaborations include work on quatsome-RGD nanoarchitectonic surfaces for integrin adhesion and polysaccharide-based nanocarriers for lysosomal delivery. Her publications consistently emphasize technological applications in muscular dystrophy , neurodegenerative diseases , and biomaterial design , reflecting IBEC’s mission of translating bioengineering research into clinical solutions.

• Bioengineering
• Nanotechnology
• Biosensors
• +7 more

David Esporrín Ubieto is a researcher at the Institute for Bioengineering of Catalonia (IBEC), focusing on smart nano-bio-devices for biomedical applications. His work spans advanced materials engineering, targeted therapeutic systems, and overcoming physiological barriers through nanotechnology. Current affiliation: IBEC Research focus: Nanomotors , Biosensors , 3D Bioprinting , and Hydrogel Applications His recent publications (2025-2022) explore enzyme-powered nanomotors for mucus penetration, hybrid nanomaterials for photothermal therapy, and biomimetic systems for tissue regeneration. Key keywords include Nanotechnology, Bioengineering, and Targeted Therapeutics. Projects mentioned in IBEC news include Fibrosens (muscular dystrophy sensors) and CHEMTUBIO (enzymes with therapeutic potential). While specific scientific awards are not listed, his work aligns with IBEC's innovation-driven mission in bioengineering solutions for hospitals and industry.